Protein Core (William Marzluff., Faculty Director) Nucleic acid technology has evolved at an extraordinary rate and will, for all intents and purposes, complete sequencing of the human genome within the next CCSG five-year cycle. Other efforts will create substantial sequence databases from the mouse, and complete sequences are extant, or soon will be, for most lower organisms. The next era of discovery will rely much less on the sequencing of unknown nucleic acid clones, and much more on detecting and identifying proteins purified by virtue of their function or interaction with other proteins. Thus, a forward-looking core facility to identify proteins and study multiple facets of protein interactions will be of increasing importance to the UNC Lineberger. Although the CCSG has not previously funded a protein core, several components are functioning at UNC. The current proposal takes those operationalized components and combines them under one administrative structure, directed by William Marzluff, Ph.D., Cancer Center Associate Director for Core Facilities and Director for the Program of Molecular Biology and Biotechnology (PMBB). The Protein Core will include: (1) a multifaceted facility for studying biochemistry and the chemistry of protein-protein interactions; (2) a peptide synthesis facility to provide peptides for study of interactions in pure systems, as reagents to disturb cellular interactions in cell culture, and for use as antigens to raise antibodies.; (3) protein purification and peptide isolation; and (4) high sensitivity peptide sequencing, involving either Edman degradation, or, increasingly mass spectroscopy analysis of peptides.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-25
Application #
6404892
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
1981-08-01
Project End
2004-11-30
Budget Start
Budget End
Support Year
25
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Lund, Jennifer L; Sanoff, Hanna K; Peacock Hinton, Sharon et al. (2018) Potential Medication-Related Problems in Older Breast, Colon, and Lung Cancer Patients in the United States. Cancer Epidemiol Biomarkers Prev 27:41-49
Smith, Jennifer S; Des Marais, Andrea C; Deal, Allison M et al. (2018) Mailed Human Papillomavirus Self-Collection With Papanicolaou Test Referral for Infrequently Screened Women in the United States. Sex Transm Dis 45:42-48
Morris, Michael J; Rumble, R Bryan; Basch, Ethan et al. (2018) Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 36:1521-1539
Hisada, Yohei; Thålin, Charlotte; Lundström, Staffan et al. (2018) Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients. Thromb Res 165:1-5
Westmoreland, Katherine D; El-Mallawany, Nader K; Kazembe, Peter et al. (2018) Dissecting heterogeneous outcomes for paediatric Burkitt lymphoma in Malawi after anthracycline-based treatment. Br J Haematol 181:853-854
Kulis, Michael; Yue, Xiaohong; Guo, Rishu et al. (2018) High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young children. Clin Exp Allergy :
Malta, Tathiane M; Sokolov, Artem; Gentles, Andrew J et al. (2018) Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell 173:338-354.e15
Wu, Jing; Frady, Lauren N; Bash, Ryan E et al. (2018) MerTK as a therapeutic target in glioblastoma. Neuro Oncol 20:92-102
Wu, Shih-Ying; Fix, Samantha M; Arena, Christopher B et al. (2018) Focused ultrasound-facilitated brain drug delivery using optimized nanodroplets: vaporization efficiency dictates large molecular delivery. Phys Med Biol 63:035002
Juliano, Rudolph L; Wang, Ling; Tavares, Francis et al. (2018) Structure-activity relationships and cellular mechanism of action of small molecules that enhance the delivery of oligonucleotides. Nucleic Acids Res 46:1601-1613

Showing the most recent 10 out of 1525 publications